Ionis Pharmaceuticals Inc (NAS:IONS)
$ 38.8 -0.28 (-0.72%) Market Cap: 5.66 Bil Enterprise Value: 4.94 Bil PE Ratio: 0 PB Ratio: 19.11 GF Score: 74/100

Ionis Pharmaceuticals Inc at SVB Leerink Global Healthcare Conference (Virtual) Transcript

Feb 26, 2021 / 04:20PM GMT
Release Date Price: $52.4 (-1.89%)
Mani Foroohar
SVB Leerink LLC, Research Division - MD of Genetic Medicines & Senior Research Analyst

Hello, everyone, and welcome back to the next session in our suite of presentations for our 10th Annual Global Healthcare Conference. I'm Mani Foroohar, senior analyst for our genetic medicines team, and I'm fortunate to host Eric Swayze and Wade Walke from Ionis Pharmaceuticals. How are you guys doing today?

Eric E. Swayze
Ionis Pharmaceuticals, Inc. - EVP of Research

Doing Great. Glad to be here. Thanks for the opportunity.

Questions & Answers

Mani Foroohar
SVB Leerink LLC, Research Division - MD of Genetic Medicines & Senior Research Analyst

Okay. So I want to start just by working through some of the sort of key questions around the pipeline you guys have already reported for the quarter. So those numbers are already out. So we can just dive into the science. For those in the investment -- in the investor audience, if you have any specific questions, things you wanted us to follow-up on,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot